News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
623,821 Results
Type
Article (47909)
Company Profile (218)
Press Release (575694)
Section
Business (177280)
Career Advice (2587)
Deals (32643)
Drug Delivery (123)
Drug Development (79068)
Employer Resources (164)
FDA (16307)
Job Trends (13647)
News (313952)
Policy (32505)
Tag
2024 BioCapital Digital (10)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (6)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (13)
2024 Biotech Beach Digital (6)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (3)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (4)
2025 Lone Star Bio Digital (5)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2422)
Academic (1)
Accelerated approval (3)
Adcomms (29)
Allergies (77)
Alliances (44827)
ALS (88)
Alzheimer's disease (1433)
Antibody-drug conjugate (ADC) (133)
Approvals (16276)
Artificial intelligence (247)
Autoimmune disease (19)
Automation (10)
Bankruptcy (328)
Best Places to Work (10194)
BIOSECURE Act (21)
Biosimilars (114)
Biotechnology (113)
Bladder cancer (63)
Brain cancer (26)
Breast cancer (248)
Cancer (1993)
Cardiovascular disease (173)
Career advice (2153)
Career pathing (33)
CAR-T (143)
Cell therapy (413)
Cervical cancer (19)
Clinical research (64152)
Collaboration (741)
Compensation (457)
Complete response letters (29)
COVID-19 (2662)
CRISPR (40)
C-suite (209)
Cystic fibrosis (95)
Data (1885)
Decentralized trials (2)
Denatured (27)
Depression (49)
Diabetes (258)
Diagnostics (5623)
Digital health (16)
Diversity (8)
Diversity, equity & inclusion (42)
Drug discovery (110)
Drug pricing (120)
Drug shortages (32)
Duchenne muscular dystrophy (88)
Earnings (70127)
Editorial (39)
Employer branding (20)
Employer resources (146)
Events (94572)
Executive appointments (625)
FDA (17424)
Featured Employer (42)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (631)
Gene editing (99)
Generative AI (23)
Gene therapy (298)
GLP-1 (794)
Government (4023)
Grass and pollen (4)
Guidances (45)
Healthcare (16038)
Huntington's disease (24)
IgA nephropathy (26)
Immunology and inflammation (124)
Indications (26)
Infectious disease (2802)
Inflammatory bowel disease (136)
Inflation Reduction Act (9)
Influenza (47)
Intellectual property (85)
Interviews (475)
IPO (15349)
IRA (49)
Job creations (3861)
Job search strategy (1808)
Kidney cancer (10)
Labor market (31)
Layoffs (508)
Leadership (20)
Legal (7874)
Liver cancer (72)
Lung cancer (292)
Lymphoma (136)
Machine learning (4)
Management (58)
Manufacturing (284)
MASH (66)
Medical device (11545)
Medtech (11549)
Mergers & acquisitions (17763)
Metabolic disorders (707)
Multiple sclerosis (75)
NASH (23)
Neurodegenerative disease (91)
Neuropsychiatric disorders (31)
Neuroscience (1943)
NextGen: Class of 2025 (5532)
Non-profit (3431)
Northern California (2326)
Now hiring (27)
Obesity (392)
Opinion (255)
Ovarian cancer (66)
Pain (83)
Pancreatic cancer (74)
Parkinson's disease (139)
Partnered (17)
Patents (209)
Patient recruitment (91)
Peanut (46)
People (52295)
Pharmaceutical (90)
Pharmacy benefit managers (21)
Phase I (19764)
Phase II (27866)
Phase III (21731)
Pipeline (1054)
Podcasts (103)
Policy (134)
Postmarket research (2610)
Preclinical (8012)
Press Release (50)
Prostate cancer (96)
Psychedelics (37)
Radiopharmaceuticals (242)
Rare diseases (381)
Real estate (5402)
Recruiting (65)
Regulatory (22670)
Reports (35)
Research institute (2230)
Resumes & cover letters (426)
Rett syndrome (3)
RNA editing (4)
RSV (44)
Schizophrenia (76)
Series A (119)
Series B (76)
Service/supplier (13)
Sickle cell disease (54)
Southern California (2000)
Special edition (18)
Spinal muscular atrophy (154)
Sponsored (32)
Startups (3332)
State (2)
Stomach cancer (16)
Supply chain (64)
The Weekly (73)
United States (20070)
Vaccines (742)
Venture capitalists (38)
Webinars (13)
Weight loss (291)
Women's health (34)
Worklife (18)
Date
Today (225)
Last 7 days (697)
Last 30 days (2737)
Last 365 days (32686)
2025 (7987)
2024 (33902)
2023 (37956)
2022 (48577)
2021 (52358)
2020 (49729)
2019 (40560)
2018 (30960)
2017 (31274)
2016 (30064)
2015 (33729)
2014 (27400)
2013 (23041)
2012 (24703)
2011 (25297)
2010 (23250)
Location
Africa (785)
Alabama (41)
Alaska (7)
Arizona (183)
Arkansas (12)
Asia (38852)
Australia (6260)
California (5251)
Canada (1646)
China (457)
Colorado (239)
Connecticut (267)
Delaware (131)
Europe (87709)
Florida (792)
Georgia (172)
Hawaii (1)
Idaho (44)
Illinois (453)
India (24)
Indiana (253)
Iowa (9)
Japan (142)
Kansas (86)
Kentucky (21)
Louisiana (6)
Maine (62)
Maryland (821)
Massachusetts (4059)
Michigan (177)
Minnesota (330)
Mississippi (1)
Missouri (64)
Montana (18)
Nebraska (22)
Nevada (51)
New Hampshire (53)
New Jersey (1533)
New Mexico (26)
New York (1485)
North Carolina (916)
North Dakota (6)
Northern California (2326)
Ohio (160)
Oklahoma (10)
Oregon (32)
Pennsylvania (1158)
Puerto Rico (10)
Rhode Island (20)
South America (1161)
South Carolina (16)
South Dakota (1)
Southern California (2000)
Tennessee (84)
Texas (760)
Utah (142)
Virginia (125)
Washington D.C. (60)
Washington State (494)
West Virginia (3)
Wisconsin (51)
623,821 Results for "galderma pharma s a".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Galderma’s Nemluvio® (Nemolizumab) Approved in the European Union for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis
February 14, 2025
·
13 min read
Press Releases
Galderma’s Nemluvio® (Nemolizumab) Granted Marketing Authorization in the United Kingdom and Switzerland for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis
February 18, 2025
·
7 min read
Press Releases
CHMP Recommends Approval of Galderma’s Nemolizumab for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis in the European Union
December 13, 2024
·
14 min read
Government
Trump’s Whiplash Policies Keep Pharmas on Their Toes
As the Q4 2024 pharma earnings period rolls on through the first month of President Donald Trump’s second term, executives find themselves faced with policy questions ranging from the Inflation Reduction Act to RFK Jr.
February 12, 2025
·
4 min read
·
Annalee Armstrong
Press Releases
Galderma’s Phase III OLYMPIA 1 Data Published in JAMA Dermatology Demonstrate That Nemolizumab Improves Core Signs and Symptoms of Prurigo Nodularis
November 28, 2024
·
10 min read
Podcasts
Trump’s Pharma Tariffs, Monarez for CDC, Novo’s New Obesity Play, More
President Donald Trump continues to warn of tariffs on the pharmaceutical industry; Susan Monarez replaces Dave Weldon as CDC director nominee; Novo Nordisk joins the triple-G race; Alnylam wins approval for Amvuttra in ATTR-CM; and Cassava Sciences ends development of simufilam in Alzheimer’s.
March 26, 2025
·
1 min read
·
Heather McKenzie
Press Releases
AMWC 2025: Galderma Pushes the Innovation Frontier With Updates From Its Unparalleled Portfolio Designed to Meet the Needs of the Aesthetic Community
March 20, 2025
·
16 min read
Podcast
Trump’s Pharma Tariffs, Another GLP-1 Compounding Lawsuit, Bluebird’s Bailout, More
As FDA seeks to rehire some fired employees, Donald Trump threatens to enact tariffs on pharma companies unless they reshore manufacturing; another lawsuit hits the complex GLP-1 compounding space as Eli Lilly offers expanded Zepbound options; and struggling gene therapy biotech bluebird bio goes private in an attempt to stay solvent.
February 26, 2025
·
1 min read
·
Heather McKenzie
Press Releases
AAD 2025: Galderma to Present Extensive Updates From Across Its Dermatology Portfolio, Demonstrating Its Category Leadership and Strong Momentum
March 3, 2025
·
10 min read
Press Releases
Galderma Receives U.S. FDA Approval for Nemluvio® (Nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis
December 16, 2024
·
14 min read
1 of 62,383
Next
